The Clinical and Pathological Characteristics of POLE-Mutated Endometrial Cancer: A Comprehensive Review
X Yao, M Feng, W Wang - Cancer Management and Research, 2024 - Taylor & Francis
Endometrial cancer shows high histological and molecular heterogeneity. The POLE
mutation is a significant molecular alteration in endometrial cancer, leading to the …
mutation is a significant molecular alteration in endometrial cancer, leading to the …
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection
N Galant, P Krawczyk, M Monist, A Obara… - International Journal of …, 2024 - mdpi.com
Endometrial cancer (EC) accounts for 90% of uterine cancer cases. It is considered not only
one of the most common gynecological malignancies but also one of the most frequent …
one of the most common gynecological malignancies but also one of the most frequent …
The PD-1/PD-L1 Gateway: Peripheral Immune Regulation in the Pathogenesis of Endometriosis
M Sobstyl, P Mertowska, S Mertowski… - International Journal of …, 2024 - mdpi.com
Endometriosis is a chronic inflammatory disease characterized by the presence of
endometrial-like tissue outside the uterine cavity, causing pain and infertility. Despite the …
endometrial-like tissue outside the uterine cavity, causing pain and infertility. Despite the …
FcRn Expression in Endometrial Cancer and Its Association with Clinicopathologic Features
DH Song, J Yang, CH Kim, MH Kim, JY Jo, JC Baek - Diagnostics, 2023 - mdpi.com
Background: Endometrial cancer (EC) has robust molecular diagnostic evidence that
correlates well with prognosis. In various types of cancers, FcRn has been identified as an …
correlates well with prognosis. In various types of cancers, FcRn has been identified as an …
[HTML][HTML] Correlation between estrogen receptor and programmed death ligand-1 in type I endometrial cancer
Objective To determine the effect of estrogen receptor (ER) on programmed death-ligand 1
(PD-L1) expression in type I endometrial cancer (EC). Material and Methods This …
(PD-L1) expression in type I endometrial cancer (EC). Material and Methods This …
[PDF][PDF] PD-L1 in a South African cohort of endometrial carcinomas: directions for the future
R Wadee, I Maposa - Eur. J. Gynaecol. Oncol, 2024 - oss.ejgo.net
Abstract The Programmed Death-1 (PD-1)/Programmed Death Ligand 1 (PD-L1) pathway is
the focus of numerous clinical trials on various tumours using immunotherapy. Endometrial …
the focus of numerous clinical trials on various tumours using immunotherapy. Endometrial …
为了回应用户根据美国数字千年版权法案 (DMCA) 向我们提交的投诉,我们已从此页上移除了 1 个结果。如果需要,您可以访问 LumenDatabase.org,查看导致结果遭到移除的 DMCA 投诉内容。